patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Top Rated Messages

Sorry, no rated messages found

AGORACOM Quick Tips

Small-Cap CEO Lessons - Is Your CEO Out Of Touch? ... Not Anymore

Watch
Today's Show
in 00:00:000

4-17-12, Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial for the treatment of peripheral artery disease (PAD). read more

Like Pluristem Life Systems, Inc.? Then you might also be interested in Star Navigation Systems Group Ltd.

Developer of the TERRASTARTM in-flight safety monitoring system
The first system in the world to feature real-time in-flight data monitoring and diagnostics
echnical Partnership Agreement with Astrium, a wholly owned subsidiary of EADS